Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Oct;30(4):567–571. doi: 10.1111/j.1365-2125.1990.tb03814.x

Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.

A Bossini 1, C Di Veroli 1, G Cavallotti 1, V Cagli 1
PMCID: PMC1368246  PMID: 2291869

Abstract

1. Felodipine is a new calcium-antagonist dihydropyridine derivative with a high degree of selectivity for smooth muscle of arteriolar resistance vessels, as opposed to cardiac cells. 2. In this double-blind, cross-over study the antihypertensive efficacy and tolerability of the new extended release (ER) formulation of felodipine 10 mg, once daily, in patients with mild essential hypertension was evaluated. After a 4-week single-blind placebo period 28 patients (15 males; mean age 48 +/- 12 years) were randomized to receive felodipine 10 mg ER once daily or placebo for 4 weeks and the alternative treatment for a further 4 weeks. Supine blood pressure and heart rate were measured in the out-patients department every 2 weeks, 22-24 h after the last drug administration. 3. Felodipine 10 mg ER induced a significant reduction in blood pressure in comparison with placebo (from 149 +/- 16/97 +/- 6 to 140 +/- 12/89 +/- 6 mm Hg). Heart rate remained unchanged. Seven patients dropped-out; five during felodipine ER administration and two during placebo. 4. A once daily dose of felodipine ER significantly reduces blood pressure in mild hypertensive patients 22-24 h after administration. It is well tolerated and the adverse events are related to its pharmacodynamic effects.

Full text

PDF
567

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson O., Bengtsson C., Elmfeldt D., Haglund K., Hedner T., Seideman P., Sjöberg K. H., Strömgren E., Aberg H., Ostman J. Short-term effects of felodipine, a new dihydropyridine, in hypertension. Br J Clin Pharmacol. 1984 Mar;17(3):257–263. doi: 10.1111/j.1365-2125.1984.tb02340.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Been M., Macfarlane P. W., Hillis W. S. Electrophysiological effects of felodipine. Drugs. 1985;29 (Suppl 2):76–80. doi: 10.2165/00003495-198500292-00014. [DOI] [PubMed] [Google Scholar]
  3. Culling W., Ruttley M. S., Sheridan D. J. Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease. Br Heart J. 1984 Oct;52(4):431–434. doi: 10.1136/hrt.52.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davis R. H., Burton R. H., Freeling P., Graham-Evans J. N., Goves J. R., Orne-Smith E. A., Osborne C. J., Ward D. E. Hypertension in the elderly. Its diagnosis in general practice and treatment with felodipine and metoprolol. Drugs. 1987;34 (Suppl 3):149–150. doi: 10.2165/00003495-198700343-00031. [DOI] [PubMed] [Google Scholar]
  5. Edgar B., Bengtsson B., Elmfeldt D., Lundborg P., Nyberg G., Raner S., Rönn O. Acute diuretic/natriuretic properties of felodipine in man. Drugs. 1985;29 (Suppl 2):176–184. doi: 10.2165/00003495-198500292-00032. [DOI] [PubMed] [Google Scholar]
  6. Elmfeldt D., Hedner T. Felodipine--a new vasodilator, in addition to beta-receptor blockade in hypertension. Eur J Clin Pharmacol. 1983;25(5):571–575. doi: 10.1007/BF00542340. [DOI] [PubMed] [Google Scholar]
  7. Elmfeldt D., Hedner T., Westerling S. Felodipine in hypertension--a review. J Cardiovasc Pharmacol. 1987;10 (Suppl 1):S154–S160. [PubMed] [Google Scholar]
  8. Hedner T., Elmfeldt D., Dahlöf C., Sjögren E. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension. Drugs. 1987;34 (Suppl 3):125–131. doi: 10.2165/00003495-198700343-00027. [DOI] [PubMed] [Google Scholar]
  9. Hedner T., Samuelsson O., Sjögren E., Elmfeldt D. Treatment of essential hypertension with felodipine in combination with a diuretic. Eur J Clin Pharmacol. 1986;30(2):133–139. doi: 10.1007/BF00614290. [DOI] [PubMed] [Google Scholar]
  10. Hedner T., Sjögren E., Elmfeldt D. Antihypertensive effects and pharmacokinetics of felodipine combined with a beta-blocker and a diuretic. J Cardiovasc Pharmacol. 1987;10 (Suppl 1):S177–S184. doi: 10.1097/00005344-198710001-00032. [DOI] [PubMed] [Google Scholar]
  11. Hills M., Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol. 1979 Jul;8(1):7–20. doi: 10.1111/j.1365-2125.1979.tb05903.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ljung B. Vascular selectivity of felodipine. Drugs. 1985;29 (Suppl 2):46–58. doi: 10.2165/00003495-198500292-00011. [DOI] [PubMed] [Google Scholar]
  13. Lorimer A. R., McAlpine H. M., Rae A. P., Simpson I. A., Barbour M. P., Forret E. A., Hill T. W., Lawrie T. D. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients. Drugs. 1985;29 (Suppl 2):154–157. doi: 10.2165/00003495-198500292-00026. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES